Physician

Vinni Juneja, MD

According to 2025 Medicare claims, Vinni Juneja, MD (NPI: 1639223522) practices hematology/oncology in the Frederick-Gaithersburg-Bethesda, MD market, with the plurality of this provider's patient population coming from Montgomery, MD. This provider's primary affiliated billing organization is MARYLAND ONCOLOGY HEMATOLOGY, P.A. (NPI: 1821271032; TIN: 113652573) and primary practice location at 20904-7917.

Juneja's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 699 traditional Medicare patients, billed 247,298 HCPCS/CPT codes, and received $3,312,667 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,090 prescription claims across 174 beneficiaries totaling $3,081,407 in drug costs, led by Lynparza (Olaparib). DME data shows 16 claims. Open Payments data shows 208 records totaling $142,202. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $586,052 to $3,312,667. Similarly, Part D prescription costs have risen steadily, from $497,652 to $3,081,407. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.7M$3.3M2015 Medicare payment: $586,052 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $615,290 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $648,974 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $896,887 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $531,002 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $794,494 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,481,658 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,148,126 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $3,004,995 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,312,667 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201536541,644$586,052
201641948,899$615,290
201746062,367$648,974
201847962,975$896,887
201937436,524$531,002
202033447,209$794,494
202134081,733$1,481,658
2022372163,451$2,148,126
2023578213,124$3,004,995
2024699247,298$3,312,667

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.5M$3.1M2015 Drug cost: $497,652 (USD; Tot_Drug_Cst)2016 Drug cost: $950,072 (USD; Tot_Drug_Cst)2017 Drug cost: $1,137,520 (USD; Tot_Drug_Cst)2018 Drug cost: $1,275,005 (USD; Tot_Drug_Cst)2019 Drug cost: $606,266 (USD; Tot_Drug_Cst)2020 Drug cost: $813,456 (USD; Tot_Drug_Cst)2021 Drug cost: $1,041,580 (USD; Tot_Drug_Cst)2022 Drug cost: $1,587,899 (USD; Tot_Drug_Cst)2023 Drug cost: $1,514,636 (USD; Tot_Drug_Cst)2024 Drug cost: $3,081,407 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201574609$497,652
201698757$950,072
2017110869$1,137,520
2018116905$1,275,005
201983448$606,266
202051224$813,456
202164298$1,041,580
202286473$1,587,899
2023112653$1,514,636
20241741,090$3,081,407

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$13K$26K2016 Medicare payment: $25,569 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $15,086 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $15,101 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $9,416 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $1,728 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $1,744 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $301 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/R59$25,569
2017N/R84$15,086
2018N/R128$15,101
2019N/R108$9,416
2020N/R11$1,728
2021N/R11$1,744
2022N/RN/RN/R
2023N/RN/RN/R
2024N/R16$301

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more234533$106
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more182328$75
96372Injection of drug or substance under skin or into muscle196411$12
80053Blood test, comprehensive group of blood chemicals2801,061$10
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count3061,207$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
LynparzaOlaparib21630$338,507
LenalidomideLenalidomide31700$324,855
XtandiEnzalutamide23690$319,811
ErleadaApalutamide18540$238,973
JakafiRuxolitinib Phosphate12360$193,946

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
Q0511Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day periodNN/R16$301

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.189$6,301PFIZER INC.
Research PaymentsReported research-related payment or transfer-of-value amount.19$135,901Janssen Research & Development, LLC
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Vinni Juneja, MD?

Tedicare shows public-source Medicare data for Vinni Juneja, MD (NPI 1639223522), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Vinni Juneja, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Vinni Juneja, MD?

Vinni Juneja, MD is linked to MARYLAND ONCOLOGY HEMATOLOGY, P.A. (billing NPI 1821271032) in the available physician profile data.

Does Vinni Juneja, MD have Open Payments data?

Vinni Juneja, MD has 208 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.